Login

Teleborsa S.p.A. interviews Alessio Aceti, CEO of Sababa Security. 00:10:00

Share On Facebook Share On Twitter

Alessio Aceti is the CEO of Sababa Security.

Recent Videos

00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
00:10:00
Jim Woody on Leading 180 Life Sciences: Advancing Breakthrough Biologic Therapies for Inflammation, Fibrosis, and Pain|Dr. Jim Woody,CEO,180 Life Sciences

Suggestions

00:10:00
Manchester Product Specification Showroom: Explore Our Diverse Range | Nick Latham - Chairman of James Latham
00:10:00
Navigating the Challenges of Long-Short Funds: Insights from Jacob Doft of Highline Capital | Jacob Doft - CEO, Highline Capital Management
00:10:00
Serene Confidence: Embracing Slowdowns | Ryan Detrick - Chief Market Strategist of Harbor Wealth Management
00:10:00
Michael Harris Discusses Quantitative Investing and Trend Following at Quest Partners
00:10:00
Mark R. Munch, Ph.D.President of Bruker Nano
00:10:00
PYX Resources CEO Oliver Hasler on First Monazite-Rich Zircon Export to China | Oliver Hasler, CEO , PYX Resources Ltd.
00:10:00
Mastering Market Challenges and Expansion: A Conversation with South Africa's Real Estate Chief | Izak Petersen , CEO ,Dipula Income Fund Ltd.
00:10:00
Missouri Copper: Positioned for Growth in the Copper-Cobalt Hub of the DRC
00:10:00
Presentation on Orca Gold's African Mining Ventures
00:10:00
A venture we back offers one or more of the factors:Significant technology or business model innovation|Peter Buckland,General Partner and COO,Khosla Ventures
00:10:00
Navigating Social Change and Investment: Insights from Paul Niven, Fund Manager at F&C Investment Trust
00:10:00
Lexington Gold Set to List on London AIM Exchange After Reverse Takeover | Dr. Bernard Olivier, CEO , Lexington Gold Ltd.

© 2017 - Neuhu+